Bristol Myers Squibb Co. Stock Rises 4.8%, Outperforms Peers
Dow Jones2026/10/20 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. rose 4.8% to $61.68 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.3% to 7,712.57 and the Dow Jones Industrial Average rising 1.0% to 52,495.88.
The stock's rise snapped a two-day losing streak.
Bristol Myers Squibb Co. closed 10.1% below its 52-week high of $68.64, which the company achieved on August 19th.
The stock outperformed some of its peers, as Johnson & Johnson rose 2.2% to $259.36, Pfizer Inc. rose 2.3% to $30.11, and Abbott Laboratories fell 1.55% to $102.45.
Trading volume totaled 11.9 million, compared to the 50-day average of 11.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 20, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The commercialization process of nuclear power is progressing slower than expected; Barclays is bearish on NuScale Power (SMR.US)
Barclays has downgraded NuScale Power (SMR.US) from "Hold" to "Underweight," with a target price of $5.
Nomura: Bond short squeeze and AI selloff trigger cross-asset 'reverse dispersion' rotation, with capital flowing into value stocks and small-cap stocks
Nomura Securities analyst McElligott believes that bond tightening and turmoil in the field of artificial intelligence will lead to a market reversal.
AI Is Splitting Software Into Winners and Losers, Citi’s Tyler Radke Says
KOSPI Jumps 3.54%, Nikkei Gains 1.43%, But How Is Oil Driving the Rebound?
Crypto prices
More
